Health systems, lawmakers and primary care providers are answering a call coming from women to provide more menopause care. Every year, 1.3 million American women reach menopause, which has an average ...
Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) announces a Statewide Educational Seminar Series on the TCUP ...
17hon MSN
Reform of federal drug discount program should target misaligned incentives, researchers say
The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients ...
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...
Violent incidents are increasing at health care settings, including hospitals. Medical professionals worry about their safety ...
Syntara Limited ( OTCPK:PMXSF) Shareholder/Analyst Call September 29, 2025 9:00 PM EDT ...
Discover Syntara’s latest Phase 2a trial results for amsulostat in myelofibrosis, showing breakthrough symptom relief and strong pipeline updates.
Beyond credentialing, PRS assists medical facilities with interim staffing, connecting them with certified, experienced, and passionate professionals.
From fatigue to neuropathy, managing treatment-related side effects is central to improving quality of life in breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback